Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike
Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike
批准号:
10453964
负责人:
Priyamvada Acharya
金额:
$76.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-01 至 2027-01-31
关键词:
2019-nCoVAntibodiesAntigensBiochemicalBiochemistryBiologicalBiophysicsCOVID-19CommunicationComputing MethodologiesCoronavirusCoronavirus spike proteinCryoelectron MicroscopyDataData SetElectron MicroscopyEmergency SituationEngineeringEvolutionFc ReceptorFundingFutureGoalsGrantImmune EvasionIn VitroKineticsLeadLife Cycle StagesLinkMeasuresMethodsMinkMolecularMolecular ConformationMutagenesisMutationNegative StainingPathogenesisPeptide HydrolasesPeptidesPopulationPositioning AttributePredispositionPropertyProtein ConformationProteinsProteolysisProtomerRecurrenceReportingResearchResistanceResolutionRoleSARS-CoV-2 B.1.1.7SARS-CoV-2 B.1.351SARS-CoV-2 B.1.617.2SiteStructureSurfaceTMPRSS2 geneTechniquesTechnologyUnited States National Institutes of HealthVaccine DesignVaccinesVariantViralVirusWorkX-Ray Crystallographyadvanced simulationbasebetacoronavirusbiophysical analysiscombatcomputer studiesdesignexpectationexperimental studyglobal healthhealth economicsin vivoinnovationinsightneutralizing antibodynovel vaccinespandemic diseaseprotein structurereceptor bindingreconstructionstructural biologyvaccine developmentvaccine hesitancyvariants of concern
中文摘要
天然和工程变异对SARS-CoV-2刺突结构和生物物理特性的影响
由SARS-CoV-2引起的COVID-19已经摧毁了全球健康和经济。疫苗正在
在世界范围内部署,以控制大流行,虽然出现了快速传播的“变种,
”(《明史》)引起了人们的关注。刺突(S)蛋白的突变由于其
在病毒生命周期中起重要作用,并且是中和抗体的主要靶标。广泛
疫苗的犹豫和目前德尔塔变异的传播为疫苗的出现提供了肥沃的土壤,
抗性变体。我们和其他人已经表明,变体使用大量的策略来修饰抗体,
受体相互作用表面和刺突构象,导致抗体逃避和更大的感染性。
在过去的两年里,我们利用美国国立卫生研究院的紧急补充资金,研究了SARS的结构,
CoV-2S蛋白,并建立了涵盖结构,生物化学,生物物理学和生物化学的工作流程。
计算在这里,我们建议继续进行解开变异S蛋白影响的基本工作
突变,并加强我们对刺突结构的理解,以进一步努力预测病毒的位置
并为新的疫苗设计提供信息。这项资助的科学前提是,
结构和变构将提供对其功能的深入了解,为疫苗开发提供信息,并提供
将刺突结构与β-CoV复制、进化和免疫相关所必需的机制信息
逃避这项资助的创新来自于我们开发的用于结构分析的技术,
S蛋白:结合冷冻电子显微镜(cryo-EM)的综合结构生物学管道,阴性
染色电子显微镜(NSEM)和X射线晶体学,计算方法,以及生物化学
和生物物理分析以研究刺突的结构和功能特性,包括弗林蛋白酶裂解,
受体结合和抗原性。
英文摘要
Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike
COVID-19, caused by SARS-CoV-2, has devasted global health and economics. Vaccines are being
deployed worldwide to gain control of the pandemic, although emergence of fast-spreading “variants of
concern” (VOCs) have caused concern. Mutations in the spike (S) protein are under scrutiny due to its
essential role in the virus life cycle, and being the dominant target of neutralizing antibodies. Widespread
vaccine hesitancy and the current spread of the Delta variant provide fertile ground for emergence of vaccine-
resistant variants. We and others have shown that variants use a plethora of strategies to modify antibody and
receptor interactive surfaces, and spike conformation, resulting in antibody evasion and greater infectivity.
Over the last two years, utilizing urgent supplement funding from the NIH, we studied the structures of SARS-
CoV-2 S proteins and have established workflows spanning structure, biochemistry, biophysics and
computation. Here we propose to continue the essential work of detangling the effects of variant S protein
mutations, and to enhance our understanding of spike structure to further efforts to predict where the virus is
heading and to inform novel vaccine designs. The scientific premise of this grant is that understanding spike
structure and allostery will provide insights into its function, inform vaccine development, and provide
mechanistic information essential for relating spike structure to beta-CoV replication, evolution, and immune
evasion. The innovations in this grant derive from technologies we have developed for structural analyses of
the S protein: an integrative structural biology pipeline combines cryo-electron microscopy (cryo-EM), Negative
Stain Electron Microscopy (NSEM) and X-ray crystallography, with computational methods, and biochemical
and biophysical analyses to study structural and functional properties of the spike, including furin cleavage,
receptor binding, and antigenicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10643907
-
项目类别:
-
资助金额:$47.26万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike
-
批准号:10558637
-
项目类别:
-
资助金额:$76.25万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound
-
批准号:10506669
-
项目类别:
-
资助金额:$87.01万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Duke Center for HIV Structural Biology
-
批准号:10643906
-
项目类别:
-
资助金额:$548.85万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Core 1 - Structural Biology Core
-
批准号:10506664
-
项目类别:
-
资助金额:$89.03万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Administrative Core
-
批准号:10506662
-
项目类别:
-
资助金额:$38.67万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies
-
批准号:10458981
-
项目类别:
-
资助金额:$150.46万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Duke Center for HIV Structural Biology
-
批准号:10506661
-
项目类别:
-
资助金额:$550.51万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Core 1 - Structural Biology Core
-
批准号:10643911
-
项目类别:
-
资助金额:$111.15万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies
-
批准号:10680388
-
项目类别:
-
资助金额:$155.21万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound
-
批准号:10643926
-
项目类别:
-
资助金额:$118.89万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1
-
批准号:10490900
-
项目类别:
-
资助金额:$69.54万
-
财政年份:2021
-
负责人:Priyamvada Acharya
-
依托单位:
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1
-
批准号:10403172
-
项目类别:
-
资助金额:$70.49万
-
财政年份:2021
-
负责人:Priyamvada Acharya
-
依托单位:
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1
-
批准号:10682532
-
项目类别:
-
资助金额:$68.34万
-
财政年份:2021
-
负责人:Priyamvada Acharya
-
依托单位:
Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics development
-
批准号:10265660
-
项目类别:
-
资助金额:$77.13万
-
财政年份:2020
-
负责人:Priyamvada Acharya
-
依托单位:
Structure and dynamics of a functional cavity in the HIV-1 Envelope, and its role in conformational changes required for infection
-
批准号:10083703
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2020
-
负责人:Priyamvada Acharya
-
依托单位:
Structure and dynamics of a functional cavity in the HIV-1 Envelope, and its role in conformational changes required for infection
-
批准号:9927124
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2020
-
负责人:Priyamvada Acharya
-
依托单位:
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection
-
批准号:10552588
-
项目类别:
-
资助金额:$77.08万
-
财政年份:2019
-
负责人:Priyamvada Acharya
-
依托单位:
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection
-
批准号:10090565
-
项目类别:
-
资助金额:$73.92万
-
财政年份:2019
-
负责人:Priyamvada Acharya
-
依托单位:
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection
-
批准号:10331729
-
项目类别:
-
资助金额:$77.97万
-
财政年份:2019
-
负责人:Priyamvada Acharya
-
依托单位:
海外基金